Disease | hyperprolactinemia |
Comorbidity | C0021053|immune disorders |
Sentences | 1 |
PubMedID- 25717285 | In addition, the ability to regulate prl levels with selective nr4a2 antagonists may provide novel approaches to manage hyperprolactinemia associated with other autoimmune disorders and conditions. |
Page: 1